Corpus ID: 32019584

[Non-specific immunotherapy for the treatment of allergic diseases].

@article{Kupczyk2000NonspecificIF,
  title={[Non-specific immunotherapy for the treatment of allergic diseases].},
  author={M. Kupczyk and P. Kuna},
  journal={Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego},
  year={2000},
  volume={8 47},
  pages={
          309-15
        }
}
  • M. Kupczyk, P. Kuna
  • Published 2000
  • Medicine
  • Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
IgE antibodies play a key role in the development of allergic reactions. Non-specific immunotherapy which enables to control the IgE dependent response at either the synthesis level or the effector phase can be an effective therapeutic agent for atopic diseases. To decrease the quantity of IgE anti-IgE molecules have been developed. Humanized monoclonal antibodies (mAbs) CGP 51901, CGP 56901 and rhuMAb E25 are currently under clinical studies. They bind to the C epsilon 3 domain of human free… Expand